Net revenue declined slightly while EBITDA and EBIT losses narrowed year-over-year. Strategic collaborations and new funding facilities support Simris Group's focus on ADC payload technology and bioconjugate innovation.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
